OpenVSafe by OpenVAERS
Search V-safe

4WM-33674-12229

2 vaccinations 2 coded responses 11 check-ins 2 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
352 / AL
Registered
2021-01-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-13
    Registered in v-safe
  2. 2021-01-13
    Dose 1 — Moderna
  3. 2021-01-13
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Diarrhea
    Adult check-in
  4. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Diarrhea · Be unable to work
    Adult check-in
  5. 2021-01-14
  6. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Diarrhea
    Adult check-in
  9. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  10. 2021-01-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Panic attack — Feeling: Fair · Headache
    Free text: Panic attack during the night
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2021-01-22
    Health check-in — day 7, dose 1
    Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-01-27
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-02-03
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-02-10
    Dose 2 — Moderna
  16. 2022-02-10
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Dyspnoea, Fatigue, Memory impairment — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Fatigue. Memory fog. COVID. Shortness of breath
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-02-10
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-02-11
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Moderna
22021-02-10Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-01-14 priority 2/3
2021-01-15 priority 2/3
2022-02-10 Successful
2022-02-11
Participant prefers to complete VAERS report online

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-18

Systemic reaction (other): Panic attack during the night

Release 11 — 12 months, dose 2

2022-02-10

Symptoms: Fatigue. Memory fog. COVID. Shortness of breath

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDMemory impairment · · ✓
SROPanic attack ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release